Background. Pre-eclampsia and eclampsia are major obstetric disorders that complicate 2–10% of pregnancies. The current management focuses on early detection, prevention, monitoring, and timely delivery.
The objective of the study was to evaluate the effectiveness of the Fetal Medicine Foundation (FMF) early pregnancy screening model and to identify the risk factors for pre-eclampsia.
Material and methods. This longitudinal study was conducted on 1,650 pregnant women during their first trimester, from June 2021 to November 2022. The participants underwent medical history review, blood pressure measurement, uterine artery Doppler ultrasound, and pregnancy-associated plasma protein A (PAPP-A) and placental growth factor (PlGF) testing per FMF criteria. High-risk women received aspirin prophylaxis and were monitored until delivery, with pre-eclampsia onset recorded. The study also examined the risk factors in this cohort.
Results. Among 1,650 pregnant women, 163 (9.9%) had high-risk of pre-eclampsia, and 22.6% developed pre-eclampsia. Of those who developed pre-eclampsia, 14.3% had severe evolution. The mean gestational age at diagnosis was 36.6 weeks, 10.7% before 34 weeks, 21.4% between 34–37 weeks, and 67.9% at/after 37 weeks. Women with education below high school had a 5.9-fold higher pre-eclampsia risk (95% CI: 2.1–16.6). A history of hypertension led to a 22.8-fold higher risk (95% CI: 2.3–223.6).
Conclusions. FMF-based early screening should be implemented to enable timely low-dose aspirin prophylaxis, reducing pre-eclampsia incidence. Low education and hypertension increase pre-eclampsia risk, even with aspirin prophylaxis.
Keywords: pre-eclampsia, first trimester, screening.
Address for correspondence:
Nghia Quang BUI
Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho City 90000, Vietnam
E-mail: bqnghia@ctump.edu.vn; Phone +84 918-398-788
